Global Spinal Devices and Biologics Market to Grow 6.9% Annually

By · August 6, 2012 · No comments
Spine · Tagged: , , ,

The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by Reporterlink.

One of the key factors contributing to this market growth is the development of better and longer-lasting implants. The market has also been witnessing an increase in the number of strategic alliances. However, the shortage of healthcare workers and high wages could pose a challenge to the growth of this market.

Companies dominating this market include DePuy, Medtronic, Stryker and Synthes.

Posted By

Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.
←
→

© 2013 OrthoSpineNews